| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $5.1M | -59.7% |
| SG&A Expense | $4.0M | -25.8% |
| Operating Income | -$9.0M | +49.6% |
| Pre-tax Income | -$8.8M | +52.6% |
| Net Income | -$8.8M | +49.5% |
| EPS (Basic) | -$0.78 | +54.7% |
| EPS (Diluted) | -$0.78 | +54.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.0M | -28.8% |
| Current Assets | $8.1M | -29.8% |
| Total Assets | $9.7M | -27.8% |
| Current Liabilities | $2.2M | -9.0% |
| Total Liabilities | $3.4M | -14.0% |
| Stockholders' Equity | $6.3M | -33.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$8.2M | +50.3% |
| Capital Expenditures | $12K | +50.0% |
| Investing Cash Flow | -$12K | -50.0% |
| Financing Cash Flow | $5.4M | — |
| Free Cash Flow | -$8.2M | +50.3% |